GGrantIndex
← Search

IGF::OT::IGF DCTD TUMOR TISSUE ACQUISITION

$41,892N01FY2018CANIH

Leidos Biomedical Research, Inc., Frederick MD

Investigators

Abstract

NCI is requesting support to acquire serial tumor and blood samples, including pre-treatment, on-treatment, and off-treatment, from selected NCI NCORP sites for the study of mechanisms of sensitivity and resistance to anti-cancer agents.

View original record on NIH RePORTER →